Prentiss Smith & CO Inc Pfizer Inc Transaction History

Prentiss Smith & CO Inc

$148 Million
Q3 2024

A detailed history of Prentiss Smith & CO Inc transactions in Pfizer Inc stock. As of the latest transaction made, Prentiss Smith & CO Inc holds 15,827 shares of PFE stock, worth $415,300. This represents 0.31% of its overall portfolio holdings.

Number of Shares

15,827

Previous 15,827 -0.0%

Holding current value

$415,300

Previous $442,000 3.62%

% of portfolio

0.31%

Previous 0.31%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$25.89 - $29.73 $38,731 - $44,476	-1,496 Reduced 8.64%	15,827 $439,000
Q4 2023 Feb 02, 2024	SELL	$26.13 - $33.94 $13,065 - $16,970	-500 Reduced 2.81%	17,323 $498,000
Q3 2023 Oct 24, 2023	SELL	$32.09 - $37.51 $8,632 - $10,090	-269 Reduced 1.49%	17,823 $591,000
Q1 2023 Apr 28, 2023	BUY	$39.39 - $51.28 $37,184 - $48,408	944 Added 5.51%	18,092 $738,000
Q4 2022 Jan 31, 2023	SELL	$41.75 - $54.5 $167 - $218	-4 Reduced 0.02%	17,148 $879,000
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $23,265 - $27,585	-500 Reduced 2.83%	17,152 $899,000
Q4 2021 Jan 28, 2022	BUY	$41.32 - $61.25 $82,640 - $122,500	2,000 Added 12.78%	17,652 $1.04 Million
Q3 2021 Oct 19, 2021	BUY	$39.25 - $50.42 $40,113 - $51,529	1,022 Added 6.99%	15,652 $673,000
Q2 2021 Jul 15, 2021	SELL	$35.91 - $40.68 $27,973 - $31,689	-779 Reduced 5.06%	14,630 $573,000
Q4 2020 Feb 03, 2021	SELL	$33.47 - $42.56 $16,902 - $21,492	-505 Reduced 3.17%	15,409 $567,000
Q3 2020 Nov 02, 2020	BUY	$31.75 - $37.25 $172,720 - $202,640	5,440 Added 51.94%	15,914 $584,000
Q2 2020 Jul 13, 2020	SELL	$30.12 - $36.54 $9,939 - $12,058	-330 Reduced 3.05%	10,474 $342,000
Q1 2020 Apr 29, 2020	SELL	$27.03 - $38.62 $44,167 - $63,105	-1,634 Reduced 13.14%	10,804 $353,000
Q4 2019 Jan 21, 2020	SELL	$32.92 - $37.36 $23,241 - $26,376	-706 Reduced 5.37%	12,438 $487,000
Q3 2019 Nov 06, 2019	BUY	$32.49 - $42.13 $162 - $210	5 Added 0.04%	13,144 $472,000
Q2 2019 Jul 19, 2019	SELL	$36.98 - $41.52 $2,625 - $2,947	-71 Reduced 0.54%	13,139 $569,000
Q1 2019 Jul 01, 2019	BUY	$37.5 - $41.2 $41,250 - $45,320	1,100 Added 9.08%	13,210 $561,000
Q4 2018 Jan 15, 2019	SELL	$38.47 - $43.86 $19,235 - $21,930	-500 Reduced 3.97%	12,110 $529,000
Q3 2018 Oct 23, 2018	SELL	$34.47 - $41.81 $90,242 - $109,458	-2,618 Reduced 17.19%	12,610 $556,000
Q1 2018 Apr 20, 2018	BUY	$31.91 - $37.02 $10,530 - $12,216	330 Added 2.22%	15,228 $540,000
Q3 2017 Oct 23, 2017	BUY	$31.0 - $34.15 $461,838 - $508,766	14,898	14,898 $532,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prentiss Smith & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prentiss Smith & CO Inc with notifications on news.

Account

Prentiss Smith & CO Inc Pfizer Inc Transaction History